Reduced expression of intercellular adhesion molecule-1 in ovarian adenocarcinomas - PubMed (original) (raw)

Reduced expression of intercellular adhesion molecule-1 in ovarian adenocarcinomas

J M Arnold et al. Br J Cancer. 2001.

Abstract

Ovarian adenocarcinomas develop as the result of multiple genetic and epigenetic changes in the precursor ovarian surface epithelial (OSE) cells which result in a malignant phenotype. We investigated changes in gene expression in ovarian adenocarcinoma using a cDNA array containing 588 known human genes. We found that intercellular adhesion molecule-1 (ICAM-1) was expressed at lower levels in the ovarian tumour cell lines OAW42, PEO1 and JAM than in the immortalised human ovarian surface epithelial cell line HOSE 17.1. Further investigation revealed ICAM-1 was expressed in the surface epithelium of normal ovaries and both mRNA and protein expression levels were reduced in the majority of ovarian adenocarcinoma cell lines and primary tumours. ICAM-1 expression was increased in 8/8 cell lines treated with the de novo methyltransferase inhibitor 5-aza-2'-deoxycytidine, indicating that methylation of CpG islands may play a role in the down-regulation of its expression in primary tumours. There was a significant association between patients whose tumours expressed ICAM-1 and survival (P = 0.03), suggesting that expression levels of ICAM-1 may have clinical relevance.

Copyright 2001 Cancer Research Campaign

PubMed Disclaimer

Similar articles

Cited by

References

    1. Mol Med. 1999 Sep;5(9):606-16 - PubMed
    1. Cancer Lett. 1999 Aug 3;142(2):201-6 - PubMed
    1. Cancer Res. 1979 Nov;39(11):4449-59 - PubMed
    1. Cancer Res. 1983 Nov;43(11):5379-89 - PubMed
    1. J Natl Cancer Inst. 1984 Mar;72(3):513-21 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources